Retraction
Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic
Paper Information
Record ID:
30841
Journal:
Publication Date:
November 13, 2020
Retraction Date:
July 15, 2021
(4.4 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
Country:
🇪🇬 EgyptArticle Type:
Publisher:
Research Square
Open Access:
Yes
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed
Retraction Details
Citations (37)
37
Total Citations15
Post-Retraction(40.5%)
21
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
10
Within 1 year
2
After 2+ years
1369
Days since retraction (latest)
Paper citing Efficacy and Safety of Ivermectin for Treatment an...
Unknown Authors
Unknown Journal
Published: Unknown
Retractions of COVID-19-related Research Publications During and After the Pandemic
Ellie Rose Mattoon, A. Casadevall, Ferric C. Fang
The Journal of Law Medicine & Ethics
Published: Apr 2025
1369 days after retraction
Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial
Ananda Wijewickrema, Hasini Banneheke, A. Pathmeswaran et al. (11 authors)
BMC Infectious Diseases
Open Access
Published: Jul 2024
2 citations
2 citations
1103 days after retraction
Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review
Dena Zeraatkar, Tyler Pitre, Gareth Leung et al. (19 authors)
BMJ Medicine
Open Access
Published: Oct 2022
36 citations
36 citations
443 days after retraction
Sharp reductions in COVID-19 case fatalities and excess deaths in Peru in close time conjunction, state-by-state, with ivermectin treatments
Juan Chamie-Quintero, Jennifer A Hibberd, David Scheim
Unknown Journal
Open Access
Published: Sep 2022
2 citations
2 citations
438 days after retraction
Time to Stop Using Ineffective Covid-19 Drugs
Salim S. Abdool Karim, Nikita Devnarain
New England Journal of Medicine
Open Access
Published: Aug 2022
26 citations
26 citations
398 days after retraction
EFICACIA Y SEGURIDAD DE LA IVERMECTINA EN PACIENTES CON COVID-19 CON SINTOMAS LEVES: REVISIÓN SISTEMÁTICA Y META-ANÁLISIS
Henry Marcelo Rodríguez Pérez, María Fidelia Cárdenas Marrufo, Carlos Enrique Pérez Osorio et al. (4 authors)
International Journal of Health Science
Published: Jul 2022
357 days after retraction
Randomized trials - Ivermectin repurposing for COVID-19 treatment of outpatients with mild disease in primary health care centers
Rossana Elena Chahla, Luis Medina Ruiz, Teresa Mena et al. (9 authors)
Research Society and Development
Open Access
Published: Jun 2022
341 days after retraction
Cluster Randomised Trials - Ivermectin Repurposing for Covid-19 Treatment of Outpatients with Mild Disease in Primary Health Care Centers
Rossana Elena Chahla, Luis Medina Ruiz, Teresa Mena et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Mar 2022
4 citations
4 citations
230 days after retraction
A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody
David Scheim
International Journal of Molecular Sciences
Open Access
Published: Feb 2022
26 citations
26 citations
225 days after retraction
The impact of retracted randomised controlled trials on systematic reviews and clinical practice guidelines: a meta-epidemiological study
Yuki Kataoka, Masahiro Banno, Yasushi Tsujimoto et al. (8 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2022
3 citations
3 citations
201 days after retraction
Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
Zheng Yao Low, Ashley Jia Wen Yip, Sunil K. Lal
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Open Access
Published: Oct 2021
42 citations
42 citations
99 days after retraction
Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review
Ariel Izcovich, Sasha Peiris, Martín Ragusa et al. (7 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Aug 2021
2 citations
2 citations
37 days after retraction
Aumento do consumo de ivermectina no Brasil e o risco de surtos de escabiose
Alfredo Dias de Oliveira‐Filho, Lucas Tenorio Carmo do Nascimento Bezerra, Natalia da Silva Alves et al. (4 authors)
Research Society and Development
Published: Aug 2021
6 citations
6 citations
31 days after retraction
Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection
Raquel Cobos‐Campos, Antxon Apiñaniz, Naiara Parraza et al. (6 authors)
Current Research in Translational Medicine
Open Access
Published: Aug 2021
10 citations
10 citations
27 days after retraction
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19
Alessandro D. Santin, David Scheim, Peter A. McCullough et al. (5 authors)
New Microbes and New Infections
Open Access
Published: Aug 2021
26 citations
26 citations
19 days after retraction
Effectiveness of Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 Patients
Sabine Hazan, Sonya Davé, Anoja W. Gunaratne et al. (7 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2021
6 citations
6 citations
8 days before retraction
Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
Andrew Hill, Anna Garratt, Jacob Levi et al. (10 authors)
Open Forum Infectious Diseases
Open Access
Published: Jul 2021
68 citations
68 citations
9 days before retraction
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
Julio Vallejos, Rodrigo Zoni, María Del Carmen Bangher et al. (29 authors)
BMC Infectious Diseases
Open Access
Published: Jul 2021
103 citations
103 citations
13 days before retraction
Ivermectin and mortality in patients with COVID-19: A systematic review, meta-analysis, and meta-regression of randomized controlled trials
Ahmad Fariz Malvi Zamzam Zein, Catur Setiya Sulistiyana, Wilson Matthew Raffaelo et al. (4 authors)
Diabetes & Metabolic Syndrome Clinical Research & Reviews
Open Access
Published: Jun 2021
31 citations
31 citations
18 days before retraction
Six RCTs recently published in mainstream scientific journals that confirm major, statistically significant benefits of ivermectin against COVID-19 as reported in several prior RCTs
David Scheim
Unknown Journal
Published: May 2021
50 days before retraction
Flavonoids are promising safe therapy against COVID-19
Moza Mohamed Alzaabi, Rania Hamdy, Naglaa S. Ashmawy et al. (9 authors)
Phytochemistry Reviews
Open Access
Published: May 2021
139 citations
139 citations
54 days before retraction
Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary airway epithelium cells
Nilima Dinesh Kumar, Bram M. ter Ellen, Ellen M. Bouma et al. (14 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: May 2021
6 citations
6 citations
59 days before retraction
Cluster Randomised Trials - Ivermectin Repurposing For COVID-19 Treatment Of Outpatients With Mild Disease In Primary Health Care Centers
Rossana Elena Chahla, Luis Medina Ruiz, Teresa Mena et al. (9 authors)
Research Square (Research Square)
Open Access
Published: May 2021
11 citations
11 citations
70 days before retraction
An Updated Systematic Review and Meta-Analysis of Mortality, Need for ICU admission, Use of Mechanical Ventilation, Adverse effects and other Clinical Outcomes of Ivermectin Treatment in COVID-19 Patients
Smruti Karale, Vikas Bansal, Janaki Makadia et al. (12 authors)
medRxiv (Cold Spring Harbor Laboratory)
Published: May 2021
15 citations
15 citations
72 days before retraction
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19
Luis Garegnani, Eva Madrid, Nicolás Meza
BMJ evidence-based medicine
Published: Apr 2021
80 citations
80 citations
84 days before retraction
IVERMECTIN REPROPOSING FOR COVID-19 TREATMENT OUTPATIENTS IN MILD STAGE IN PRIMARY HEALTH CARE CENTERS
Rossana Elena Chahla, Luis Medina Ruiz, Teresa Mena et al. (9 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2021
7 citations
7 citations
107 days before retraction
The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis
Chia Siang Kow, Hamid A. Merchant, Zia Ul Mustafa et al. (4 authors)
Pharmacological Reports
Open Access
Published: Mar 2021
42 citations
42 citations
108 days before retraction
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
Eduardo López‐Medina, Pío López, Isabel Cristina Hurtado et al. (19 authors)
JAMA
Open Access
Published: Mar 2021
359 citations
359 citations
133 days before retraction
Prophylaxis for covid-19: living systematic review and network meta-analysis
Jessica J Bartoszko, Reed Siemieniuk, Elena Kum et al. (40 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2021
7 citations
7 citations
139 days before retraction
Ivermectin in the treatment of COVID-19- friend or foe?
Natalie Schellack, Neelaveni Padayachee, Gustav Schellack
South African General Practitioner
Open Access
Published: Feb 2021
2 citations
2 citations
164 days before retraction
Ivermectin shows clinical benefits in mild to moderate COVID19: A randomised controlled double blind dose response study in Lagos
O E Babalola, CO Bode, A.A. Ajayi et al. (10 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jan 2021
22 citations
22 citations
190 days before retraction
Ivermectin in the Prophylaxis and Treatment of Patients with SARS-CoV-2: A Living Systematic Review and Meta-Analysis
René Rodríguez‐Gutiérrez, Karina Raygoza-Cortez, Mariana García-Leal et al. (8 authors)
SSRN Electronic Journal
Published: Jan 2021
1 citation
1 citation
195 days before retraction
Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments
Juan Chamie-Quintero, Jennifer A Hibberd, David Scheim
SSRN Electronic Journal
Open Access
Published: Jan 2021
8 citations
8 citations
195 days before retraction
A living WHO guideline on drugs for covid-19
Arnav Agarwal, Beverley J. Hunt, Miriam Stegemann et al. (85 authors)
BMJ
Open Access
Published: Sep 2020
986 citations
986 citations
314 days before retraction
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica J Bartoszko, Dena Zeraatkar et al. (52 authors)
BMJ
Open Access
Published: Jul 2020
810 citations
810 citations
350 days before retraction
From Cold to Killer: How SARS-CoV-2 Evolved without Hemagglutinin Esterase to Agglutinate, Then Clot Blood Cells in Pulmonary and Systemic Microvasculature
David Scheim
SSRN Electronic Journal
Published: Jan 2020
14 citations
14 citations
561 days before retraction
Quick Stats
Total Citations:
37
Years Since Retraction:
4.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025